Trabectedin for advanced soft tissue sarcomas: optimizing use

por Reid, Alison, Martin-Liberal, Juan, Benson, Charlotte
Publicado 2014

Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity

por Archilla-Ortega, Adrià, Domuro, Carla, Martin-Liberal, Juan, Muñoz, Purificación
Publicado 2022

Pazopanib is an active treatment in desmoid tumour/aggressive fibromatosis

por Martin-Liberal, Juan, Benson, Charlotte, McCarty, Heather, Thway, Khin, Messiou, Christina, Judson, Ian
Publicado 2013

Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience

por Maruzzo, Marco, Martin-Liberal, Juan, Messiou, Christina, Miah, Aisha, Thway, Khin, Alvarado, Rolyn, Judson, Ian, Benson, Charlotte
Publicado 2015

Caveolin-1 in sarcomas: friend or foe?

por Sáinz-Jaspeado, Miguel, Martin-Liberal, Juan, Lagares-Tena, Laura, Mateo-Lozano, Silvia, del Muro, Xavier Garcia, Tirado, Oscar M
Publicado 2011

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours

por Martin-Liberal, Juan, Hollebecque, Antoine, Aftimos, Philippe, Jungels, Christiane, Martin-Romano, Patricia, Rodon, Jordi, Kremer, Jill Dolores, Zhang, Wei, Bendell, Johanna
Publicado 2020

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma

por Yousaf, Nadia, Harris, Samuel, Martin-Liberal, Juan, Stanway, Susannah, Linch, Mark, Ifijen, Maria, Al Muderis, Omar, Khabra, Komel, Fisher, Cyril, Noujaim, Jonathan, Judson, Ian, Benson, Charlotte
Publicado 2015

A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours

por Desai, Jayesh, Fong, Peter, Moreno, Victor, Frentzas, Sophia, Meniawy, Tarek, Markman, Ben, Voskoboynik, Mark, Rahman, Tahmina, Budha, Nageshwar, Wu, John, Marlow, Jin, Yang, Silu, Calvo, Emiliano, Martin-Liberal, Juan
Publicado 2023

SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy

por Soto-Castillo, Juan José, Llavata-Marti, Lucía, Fort-Culillas, Roser, Andreu-Cobo, Pablo, Moreno, Rafael, Codony, Carles, García del Muro, Xavier, Alemany, Ramon, Piulats, Josep M., Martin-Liberal, Juan
Publicado 2023

Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program

por Kollàr, Attila, Maruzzo, Marco, Messiou, Christina, Cartwright, Elisabeth, Miah, Aisha, Martin-Liberal, Juan, Thway, Khin, McGrath, Ellen, Dunlop, Alison, Khabra, Komel, Seddon, Beatrice, Dileo, Palma, Linch, Mark, Judson, Ian, Benson, Charlotte
Publicado 2014

The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval o...

por Ladanie, Aviv, Speich, Benjamin, Naudet, Florian, Agarwal, Arnav, Pereira, Tiago V., Sclafani, Francesco, Martin-Liberal, Juan, Schmid, Thomas, Ewald, Hannah, Ioannidis, John P. A., Bucher, Heiner C., Kasenda, Benjamin, Hemkens, Lars G.
Publicado 2018

Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

por Martin-Liberal, Juan, Alam, Salma, Constantinidou, Anastasia, Fisher, Cyril, Khabra, Komel, Messiou, Christina, Olmos, David, Mitchell, Scott, Al-Muderis, Omar, Miah, Aisha, Linch, Mark, Jones, Robin L., Scurr, Michelle, Judson, Ian, Benson, Charlotte
Publicado 2013

Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016

por Ladanie, Aviv, Schmitt, Andreas M., Speich, Benjamin, Naudet, Florian, Agarwal, Arnav, Pereira, Tiago V., Sclafani, Francesco, Herbrand, Amanda K., Briel, Matthias, Martin-Liberal, Juan, Schmid, Thomas, Ewald, Hannah, Ioannidis, John P. A., Bucher, Heiner C., Kasenda, Benjamin, Hemkens, Lars G.
Publicado 2020

First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

por Davis, Elizabeth J, Martin-Liberal, Juan, Kristeleit, Rebecca, Cho, Daniel C, Blagden, Sarah P, Berthold, Dominik, Cardin, Dana B, Vieito, Maria, Miller, Rowan E, Hari Dass, Prashanth, Orcurto, Angela, Spencer, Kristen, Janik, John E, Clark, Jason, Condamine, Thomas, Pulini, Jennifer, Chen, Xuejun, Mehnert, Janice M
Publicado 2022

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

por Choudhury, Atish D., Higano, Celestia S., de Bono, Johann S., Cook, Natalie, Rathkopf, Dana E., Wisinski, Kari B., Martin-Liberal, Juan, Linch, Mark, Heath, Elisabeth I., Baird, Richard D., García-Carbacho, Javier, Quintela-Fandino, Miguel, Barry, Simon T., de Bruin, Elza C., Colebrook, Steve, Hawkins, George, Klinowska, Teresa, Maroj, Brijesh, Moorthy, Ganesh, Mortimer, Peter G., Moschetta, Michele, Nikolaou, Myria, Sainsbury, Liz, Shapiro, Geoffrey I., Siu, Lillian L., Hansen, Aaron R.
Publicado 2022

Adjuvant dabrafenib and trametinib for patients with resected BRAF-mutated melanoma: DESCRIBE-AD real-world retrospective observational study

por Manzano, José L., Martin-Liberal, Juan, Fernández-Morales, Luis A., Benítez, Gretel, Medina Martínez, Javier, Quindós, María, García-Castaño, Almudena, Fernández, Ovidio, Simo, Rocío V., Majem, Margarita, Bellido, Lorena, Ayala de Miguel, Pablo, Campos, Begoña, Espinosa, Enrique, Macías Cerrolaza, José A., Gil-Arnaiz, Irene, Lorente, David, Rodriguez-Lescure, Alvaro, Perez, Victor N., López Castro, Rafael, Gramaje, María G., Puértolas, Teresa, Rodriguez Moreno, Juan F., Espasa Font, Laia, Belaustegui Ferrández, Guillermo, Cerezuela-Fuentes, Pablo
Publicado 2023

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

por Berry, Sneha, Giraldo, Nicolas, Nguyen, Peter, Green, Benjamin, Xu, Haiying, Ogurtsova, Aleksandra, Soni, Abha, Succaria, Farah, Wang, Daphne, Roberts, Charles, Stein, Julie, Engle, Elizabeth, Pardoll, Drew, Anders, Robert, Cottrell, Tricia, Taube, Janis M., Tran, Ben, Voskoboynik, Mark, Kuo, James, Bang, Yung-Lue, Chung, Hyun-Cheo, Ahn, Myung-Ju, Kim, Sang-We, Perera, Ayesh, Freeman, Daniel, Achour, Ikbel, Faggioni, Raffaella, Xiao, Feng, Ferte, Charles, Lemech, Charlotte, Meric-Bernstam, Funda, Werner, Theresa, Hodi, Stephen, Messersmith, Wells, Lewis, Nancy, Talluto, Craig, Dostalek, Mirek, Tao, Aiyang, McWhirter, Sarah, Trujillo, Damian, Luke, Jason, Xu, Chunxiao, BoMarelli, Qi, Jin, Qin, Guozhong, Yu, Huakui, Jenkins, Molly, Lo, Kin-Ming, Halle, Joern-Peter, Lan, Yan, Taylor, Matthew, Vogelzang, Nicholas, Cohn, Allen, Stepan, Daniel, Shumaker, Robert, Dutcus, Corina, Guo, Matthew, Schmidt, Emmett, Rasco, Drew, Brose, Marcia, Vogelzang, Nicholas, Di Simone, Christopher, Jain, Sharad, Richards, Donald, Encarnacion, Carlos, Rasco, Drew, Shumaker, Robert, Dutcus, Corina, Stepan, Daniel, Guo, Matthew, Schmidt, Emmett, Taylor, Matthew, Vogelzang, Nicholas, Encarnacion, Carlos, Cohn, Allen, Di Simone, Christopher, Rasco, Drew, Richards, Donald, Taylor, Matthew, Dutcus, Corina, Stepan, Daniel, Shumaker, Robert, Guo, Matthew, Schmidt, Emmett, Mier, James, An, Jeongshin, Yang, Yeun-yeoul, Lee, Won-Hee, Yang, Jinho, Kim, Jong-kyu, Kim, Hyun Goo, Paek, Se Hyun, Lee, Jun Woo, Woo, Joohyun, Kim, Jong Bin, Kwon, Hyungju, Lim, Woosung, Paik, Nam Sun, Kim, Yoon-Keun, Moon, Byung-In, Janku, Filip, Tan, David, Martin-Liberal, Juan, Takahashi, Shunji, Geva, Ravit, Gucalp, Ayca, Chen, Xueying, Subramanian, Kulandayan, Mataraza, Jennifer, Wheler, Jennifer, Bedard, Philippe
Publicado 2019